1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Polymerase Chain Reaction PCR
        1.2.3 Molecular Hybridization
        1.2.4 Biochip
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Third-Party Testing Agency
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2017-2028)
    2.2 Colorectal Cancer Molecular Diagnostics Growth Trends by Region
        2.2.1 Colorectal Cancer Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Colorectal Cancer Molecular Diagnostics Market Dynamics
        2.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends
        2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
        2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
        2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
        3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Revenue
    3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio
        3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2021
    3.5 Colorectal Cancer Molecular Diagnostics Key Players Head office and Area Served
    3.6 Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
    3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
    4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
    5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2017-2028)
    6.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022)
    6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2017-2028)
    7.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022)
    7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2017-2028)
    9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche Diagnostics
        11.1.1 Roche Diagnostics Company Detail
        11.1.2 Roche Diagnostics Business Overview
        11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Introduction
        11.1.4 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.1.5 Roche Diagnostics Recent Development
    11.2 Abbott
        11.2.1 Abbott Company Detail
        11.2.2 Abbott Business Overview
        11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
        11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.2.5 Abbott Recent Development
    11.3 Thermo Fisher
        11.3.1 Thermo Fisher Company Detail
        11.3.2 Thermo Fisher Business Overview
        11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Introduction
        11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.3.5 Thermo Fisher Recent Development
    11.4 Qiagen
        11.4.1 Qiagen Company Detail
        11.4.2 Qiagen Business Overview
        11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
        11.4.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.4.5 Qiagen Recent Development
    11.5 Illumina
        11.5.1 Illumina Company Detail
        11.5.2 Illumina Business Overview
        11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Introduction
        11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.5.5 Illumina Recent Development
    11.6 Biomerieux
        11.6.1 Biomerieux Company Detail
        11.6.2 Biomerieux Business Overview
        11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Introduction
        11.6.4 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.6.5 Biomerieux Recent Development
    11.7 Bio-Rad
        11.7.1 Bio-Rad Company Detail
        11.7.2 Bio-Rad Business Overview
        11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Introduction
        11.7.4 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.7.5 Bio-Rad Recent Development
    11.8 Agilent
        11.8.1 Agilent Company Detail
        11.8.2 Agilent Business Overview
        11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
        11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.8.5 Agilent Recent Development
    11.9 Daangene
        11.9.1 Daangene Company Detail
        11.9.2 Daangene Business Overview
        11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Introduction
        11.9.4 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.9.5 Daangene Recent Development
    11.10 Amoydx
        11.10.1 Amoydx Company Detail
        11.10.2 Amoydx Business Overview
        11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Introduction
        11.10.4 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
        11.10.5 Amoydx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Polymerase Chain Reaction PCR
    Table 3. Key Players of Molecular Hybridization
    Table 4. Key Players of Biochip
    Table 5. Key Players of Others
    Table 6. Global Colorectal Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2023-2028)
    Table 12. Colorectal Cancer Molecular Diagnostics Market Trends
    Table 13. Colorectal Cancer Molecular Diagnostics Market Drivers
    Table 14. Colorectal Cancer Molecular Diagnostics Market Challenges
    Table 15. Colorectal Cancer Molecular Diagnostics Market Restraints
    Table 16. Global Colorectal Cancer Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Colorectal Cancer Molecular Diagnostics Market Share by Players (2017-2022)
    Table 18. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2021)
    Table 19. Ranking of Global Top Colorectal Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
    Table 23. Date of Enter into Colorectal Cancer Molecular Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2022)
    Table 31. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2023-2028)
    Table 33. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Roche Diagnostics Company Detail
    Table 44. Roche Diagnostics Business Overview
    Table 45. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product
    Table 46. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 47. Roche Diagnostics Recent Development
    Table 48. Abbott Company Detail
    Table 49. Abbott Business Overview
    Table 50. Abbott Colorectal Cancer Molecular Diagnostics Product
    Table 51. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 52. Abbott Recent Development
    Table 53. Thermo Fisher Company Detail
    Table 54. Thermo Fisher Business Overview
    Table 55. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product
    Table 56. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 57. Thermo Fisher Recent Development
    Table 58. Qiagen Company Detail
    Table 59. Qiagen Business Overview
    Table 60. Qiagen Colorectal Cancer Molecular Diagnostics Product
    Table 61. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 62. Qiagen Recent Development
    Table 63. Illumina Company Detail
    Table 64. Illumina Business Overview
    Table 65. Illumina Colorectal Cancer Molecular Diagnostics Product
    Table 66. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Illumina Recent Development
    Table 68. Biomerieux Company Detail
    Table 69. Biomerieux Business Overview
    Table 70. Biomerieux Colorectal Cancer Molecular Diagnostics Product
    Table 71. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. Biomerieux Recent Development
    Table 73. Bio-Rad Company Detail
    Table 74. Bio-Rad Business Overview
    Table 75. Bio-Rad Colorectal Cancer Molecular Diagnostics Product
    Table 76. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Bio-Rad Recent Development
    Table 78. Agilent Company Detail
    Table 79. Agilent Business Overview
    Table 80. Agilent Colorectal Cancer Molecular Diagnostics Product
    Table 81. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. Agilent Recent Development
    Table 83. Daangene Company Detail
    Table 84. Daangene Business Overview
    Table 85. Daangene Colorectal Cancer Molecular Diagnostics Product
    Table 86. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. Daangene Recent Development
    Table 88. Amoydx Company Detail
    Table 89. Amoydx Business Overview
    Table 90. Amoydx Colorectal Cancer Molecular Diagnostics Product
    Table 91. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Amoydx Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Colorectal Cancer Molecular Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Polymerase Chain Reaction PCR Features
    Figure 3. Molecular Hybridization Features
    Figure 4. Biochip Features
    Figure 5. Others Features
    Figure 6. Global Colorectal Cancer Molecular Diagnostics Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Third-Party Testing Agency Case Studies
    Figure 9. Others Case Studies
    Figure 10. Colorectal Cancer Molecular Diagnostics Report Years Considered
    Figure 11. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Colorectal Cancer Molecular Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Colorectal Cancer Molecular Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Colorectal Cancer Molecular Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2021
    Figure 17. North America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Colorectal Cancer Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 19. United States Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Colorectal Cancer Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 23. Germany Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Region (2017-2028)
    Figure 31. China Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 39. Mexico Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 43. Turkey Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Roche Diagnostics Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 46. Abbott Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 47. Thermo Fisher Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 48. Qiagen Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 49. Illumina Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 50. Biomerieux Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 51. Bio-Rad Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 52. Agilent Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 53. Daangene Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 54. Amoydx Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed